RecruitingPhase 4NCT06093126
Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial
Studying Rare dementia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Nova Scotia Health Authority
- Principal Investigator
- Shanna C Trenaman, BScPharm, PhD
- Intervention
- Lemborexant 5 MG(drug)
- Enrollment
- 1 enrolled
- Eligibility
- All sexes
- Timeline
- 2023 – 2028
Study locations (1)
- Nova Scotia Health, Halifax, Nova Scotia, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06093126 on ClinicalTrials.govOther trials for Rare dementia
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT06973551The Benefits of Nostalgia-Based Virtual Reality Brain Health Interventions on Nostalgia Tendencies, Life Satisfaction, Psychological Well-Being, Depression Levels, and Cognitive Function in Older AdultsNational Taiwan Normal University
- RECRUITINGNANCT06831318Community Health Worker-Led Transition Support for Persons Living With Dementia and CaregiversUniversity of Texas at Austin